Asset Details
Do you wish to reserve the book?
Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis
Do you wish to request the book?
Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis
2022
Overview
As one of the most common types of pancreatic cancer, pancreatic ductal adenocarcinoma (PDAC) is highly invasive and lethal. This study aims to develop biomarkers and targets for the diagnosis and treatment of PDAC. Differentially expressed genes (DEGs) were screened via GEO2R, protein network was constructed through STRING and Cytoscape. Functional enrichment analysis was performed, followed by survival analysis and expression validation. A total of 115 DEGs were identified, including 108 upregulated and 7 downregulated genes. After enrichment, survival analysis, one potential gene, Cyclin B1 (CCNB1), was selected for further expression verification at the mRNA and protein level. Taker together, CCNB1 may act as a potential biomarker which provided new idea for elucidation of the pathogenesis of PDAC.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 631/67
/ 692/4020
/ Biomarkers, Tumor - genetics
/ Biomarkers, Tumor - metabolism
/ Carcinoma, Pancreatic Ductal - diagnosis
/ Carcinoma, Pancreatic Ductal - genetics
/ Datasets
/ Gene Expression Regulation, Neoplastic
/ Gene set enrichment analysis
/ Humanities and Social Sciences
/ Humans
/ mRNA
/ Pancreatic Neoplasms - diagnosis
/ Pancreatic Neoplasms - genetics
/ Proteins
/ Science
/ Software
/ Survival
/ Tumors
